首页> 外国专利> a method comprising administering to a patient an oral dosage form; method for minimizing an adverse side effect associated with administering lecozotan to a patient; method for administering lecozotan to a patient; method of treating alzheimer's disease in a patient; use of lecozotan in the preparation of a medicament in oral dosage form; and use of lecozotan in the preparation of a medicament in oral dosage form to minimize an adverse side effect associated with administering lecozotan to a patient.

a method comprising administering to a patient an oral dosage form; method for minimizing an adverse side effect associated with administering lecozotan to a patient; method for administering lecozotan to a patient; method of treating alzheimer's disease in a patient; use of lecozotan in the preparation of a medicament in oral dosage form; and use of lecozotan in the preparation of a medicament in oral dosage form to minimize an adverse side effect associated with administering lecozotan to a patient.

机译:一种方法,包括向患者施用口服剂型;最小化与给患者施用莱考唑有关的不良副作用的方法;向患者施用莱考唑的方法;治疗患者的阿尔茨海默氏病的方法;来克唑酮在制备口服剂型药物中的用途; Lecozotan在制备口服剂型药物中的用途,以最小化与将Lecozotan应用于患者相关的不良副作用。

摘要

METHOD OF UNDERSTANDING AN ORAL FORM OF PATIENTS TO A PATIENT; METHOD FOR MINIMIZING AN ADVERSE SIDE EFFECT ASSOCIATED WITH LECOZOTAN ADMINISTRATION TO A PATIENT; METHOD FOR ADMINISTERING LECOZOTAN TO A PATIENT; METHOD OF TREATING ALZHEIMER'S DISEASE IN A PATIENT; USE OF LECOZOTAN IN PREPARATION OF A MEDICINAL PRODUCT IN THE FORM OF ORAL DOSAGE; AND USE OF LECOZOTAN IN PREPARING AN ORAL DOSAGE MEDICINE TO MINIMIZE AN ADVERSE SIDE EFFECT ASSOCIATED WITH LECOZOTAN ADMINISTRATION TO A PATIENT. The invention relates, for example, to novel formulations and methods for the distribution of 4-cyano-N- {(2R) -2- [4- (2,3-dihydro-benzo [1,4] dioxin-5-one). il) -piperazin-1-yl] -propyl} -N-pyridin-2-yl-benzamide, their pharmaceutically acceptable salts, structurally related compounds and / or metabolites, as well as the use of these formulations and methods for treating disease.
机译:对患者了解口服形式的方法;最小化与lecozotan管理相关的不良反应的方法向患者管理莱考唑的方法;治疗患者的老年痴呆症的方法;莱考唑酮在制备口服形式药物产品中的用途;莱考唑酮在制备口服剂量药物中的作用和用途,以最大程度地减少与莱考唑胺对患者的不良影响。例如,本发明涉及用于分布4-氰基-N-{(2R)-2- [4-(2,3-二氢-苯并[1,4]二恶英-5-酮]的新型制剂和方法。 )。 il)-哌嗪-1-基]-丙基} -N-吡啶-2-基-苯甲酰胺,它们的药学上可接受的盐,结构上相关的化合物和/或代谢物,以及这些制剂的用途和治疗疾病的方法。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号